An Aluminum-Induced Increase in GFAP Is Attenuated by Some Chelators
Authors:
- Robert A YokelRYRobert A Yokel
- James P O’callaghanJOJames P O’callaghan
- 1 January 1998
- journal article
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 20 (1) , 55-60
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- STATUS AND FUTURE CONCERNS OF CLINICAL AND ENVIRONMENTAL ALUMINUM TOXICOLOGYJournal of Toxicology and Environmental Health, 1996
- The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1′ ol]-2-methyl-3-hydroxypyridin-4-one in the ratToxicology, 1996
- Evidence for energy-dependent transport of aluminum out of brain extracellular fluidToxicology, 1995
- Alterations in the glial fibrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicityToxicology in Vitro, 1994
- Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potentialJournal of Medicinal Chemistry, 1993
- Intramuscular desferrioxamine in patients with Alzheimer's diseaseThe Lancet, 1991
- General and dramatic glial reaction in Alzheimer brainsNeurology, 1990
- Patterns of gliosis in alzheimer's disease and aging cerebrumGlia, 1989
- Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous systemJournal of Neuroscience, 1987
- “Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein AAnalytical Biochemistry, 1981